• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Pacira Pharmaceuticals Inc/DE

+ Add to Watchlist

82P:GR

61.629 EUR 1.160 1.92%

As of 03:00:53 ET on 07/11/2014.

Snapshot for Pacira Pharmaceuticals Inc/DE (82P)

Open: 62.710 Day's Range: 61.629 - 62.710 Volume: 0
Previous Close: 60.469 52wk Range: 22.655 - 70.160 1-Yr Rtn: +161.81%

Stock Chart for 82P

No chart data available.
  • 82P:GR 61.629
  • 1D
  • 1M
  • 1Y
60.469
Interactive 82P Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 82P

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.0670
Est. PEG Ratio -
Market Cap (M EUR) 2,197.39
Shares Outstanding (M) 35.66
30 Day Average Volume 13
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 82P

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 82P

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company with focuses on the development, commercialization, and manufacturing of proprietary pharmaceutical products. The Company's products are used in hospitals and ambulatory surgery centers.

David M Stack "Dave"Chairman/President/CEOGary PatouChief Medical Officer
James S ScibettaSenior VP/CFOTaunia MarkvickaSenior VP/Chief Commercial Ofcr
More Company Profile & Key Executives for 82P

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil